Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Matthews

Showing results (1061-1070 of 1,238) with videos related to

Pageof 124
Sort By:
Bone Marrow Transplantation|November 24, 2004
Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: a prospective Australasian Leukaemia and Lymphoma Group StudyA Wirth, H M Prince, M Wolf, et al.
Nature|January 14, 1990
Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analoguesT D Meek, D M Lambert, G B Dreyer, et al.
The Journal of Infectious Diseases|October 1, 1994
Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials NetworkB S Graham, G J Gorse, D H Schwartz, et al.
Science Advances|September 15, 2021
Nondiffractive beam shaping for enhanced optothermal control in metal additive manufacturingThejaswi U Tumkur, Thomas Voisin, Rongpei Shi, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
A Molecular and Cellular Mechanism for Bitter Taste in the mosquito <i>Aedes aegypti</i>Leisl I Brewster, Joshua U Abel-Nwachukwu, Pei-Hsuan Wu, et al.
Science (New York, N.Y.)|December 12, 1986
HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelopeS D Putney, T J Matthews, W G Robey, et al.
AIDS (London, England)|August 19, 2004
Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolatesPrakash R Sista, Tom Melby, Donna Davison, et al.
The American Journal of Medicine|July 1, 1988
Human T-cell lymphotropic virus I and adult T-cell leukemia: report of a cluster in North CarolinaJ B Weinberg, R A Spiegel, D L Blazey, et al.
Cancer|January 1, 1994
Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical UsageE C Vonderheid, L W Diamond, W A van Vloten, et al.
Vaccine|March 10, 1998
Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, M J McElrath, T J Matthews, et al.
Pageof 124

Showing results (1061-1070 of 1,238) with videos related to

Sort By:
Pageof 124
Bone Marrow Transplantation|November 24, 2004
Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: a prospective Australasian Leukaemia and Lymphoma Group StudyA Wirth, H M Prince, M Wolf, et al.
Nature|January 14, 1990
Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analoguesT D Meek, D M Lambert, G B Dreyer, et al.
The Journal of Infectious Diseases|October 1, 1994
Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials NetworkB S Graham, G J Gorse, D H Schwartz, et al.
Science Advances|September 15, 2021
Nondiffractive beam shaping for enhanced optothermal control in metal additive manufacturingThejaswi U Tumkur, Thomas Voisin, Rongpei Shi, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
A Molecular and Cellular Mechanism for Bitter Taste in the mosquito <i>Aedes aegypti</i>Leisl I Brewster, Joshua U Abel-Nwachukwu, Pei-Hsuan Wu, et al.
Science (New York, N.Y.)|December 12, 1986
HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelopeS D Putney, T J Matthews, W G Robey, et al.
AIDS (London, England)|August 19, 2004
Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolatesPrakash R Sista, Tom Melby, Donna Davison, et al.
The American Journal of Medicine|July 1, 1988
Human T-cell lymphotropic virus I and adult T-cell leukemia: report of a cluster in North CarolinaJ B Weinberg, R A Spiegel, D L Blazey, et al.
Cancer|January 1, 1994
Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical UsageE C Vonderheid, L W Diamond, W A van Vloten, et al.
Vaccine|March 10, 1998
Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, M J McElrath, T J Matthews, et al.
Pageof 124